{"pmid":32419564,"title":"Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.","text":["Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.","This manuscript provides support for physical therapists to focus on the long-term, as well as the short-term, consequences of acute respiratory distress syndrome (ARDS) associated with COVID-19. Since late November 2019, COVID-19 has become a global health pandemic and threat. Although most people have no or mild symptoms, COVID-19 spreads aggressively and can lead to ARDS rapidly in a proportion of individuals. The evidence supports that gas exchange and countering the negative effects of bed rest and immobility are priorities in severely affected patients admitted to the intensive care unit (ICU). However, in recent years, research has focused on poor long-term functional outcomes in patients with ARDS, often associated with ICU-acquired weakness, deconditioning, and myopathies and neuropathies. In addition to physical therapists providing respiratory support in the ICU, the literature unequivocally supports the view that early intervention for ICU management of patients with ARDS secondary to COVID-19 needs to focus on reducing contributors to impaired long-term function, with direct attention paid to preventing or managing ICU-acquired weakness, deconditioning, and myopathies and neuropathies, in conjunction with respiratory care.","Physiother Theory Pract","Candan, Sevim Acaroz","Elibol, Nuray","Abdullahi, Auwal","32419564"],"abstract":["This manuscript provides support for physical therapists to focus on the long-term, as well as the short-term, consequences of acute respiratory distress syndrome (ARDS) associated with COVID-19. Since late November 2019, COVID-19 has become a global health pandemic and threat. Although most people have no or mild symptoms, COVID-19 spreads aggressively and can lead to ARDS rapidly in a proportion of individuals. The evidence supports that gas exchange and countering the negative effects of bed rest and immobility are priorities in severely affected patients admitted to the intensive care unit (ICU). However, in recent years, research has focused on poor long-term functional outcomes in patients with ARDS, often associated with ICU-acquired weakness, deconditioning, and myopathies and neuropathies. In addition to physical therapists providing respiratory support in the ICU, the literature unequivocally supports the view that early intervention for ICU management of patients with ARDS secondary to COVID-19 needs to focus on reducing contributors to impaired long-term function, with direct attention paid to preventing or managing ICU-acquired weakness, deconditioning, and myopathies and neuropathies, in conjunction with respiratory care."],"journal":"Physiother Theory Pract","authors":["Candan, Sevim Acaroz","Elibol, Nuray","Abdullahi, Auwal"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419564","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1080/09593985.2020.1766181","keywords":["acute respiratory distress sendrom","covid-19","disability","physical function","physiotherapy"],"topics":["Prevention","Treatment"],"weight":1,"_version_":1667159284500135936,"score":9.490897,"similar":[{"pmid":32293817,"title":"Rehabilitation and respiratory management in the acute and early post-acute phase. \"Instant paper from the field\" on rehabilitation answers to the Covid-19 emergency.","text":["Rehabilitation and respiratory management in the acute and early post-acute phase. \"Instant paper from the field\" on rehabilitation answers to the Covid-19 emergency.","Covid-19 is a respiratory infectious disease that can cause respiratory, physical and psychological long-term dysfunctions in patients. First recommendations on respiratory management were published, but they were not based on the specific needs due to Covid-19. In this paper we share the early experiences from the clinical field in Northern Italy, where the epidemic started in February. This paper summarizes the second webinar on Covid-19 (230 live attendees, 11,600 viewers of the recorded version) organized by the Italian Society of Physical and Rehabilitation Medicine about rehabilitation and in particular respiratory management in the acute (Intensive Care Unit - ICU) and immediate post-acute phases. There is the need to prepare for the post-acute phase. ICU length of stay is relatively long, with immobilisation in prone position. Some specific problems are described, including severe muscle weakness and fatigue, joint stiffness, dysphagia, (neuro)psychological problems, impaired functioning concerning mobility, activities of daily life and work. A lot is yet unknown and patients can experience long-term consequences as we know from the literature on the post-intensive care syndrome, but Covid-19 has unique features to be investigated and understood. As one colleague stated during the Covinar: this is a marathon, not a sprint....","Eur J Phys Rehabil Med","Kiekens, Carlotte","Boldrini, Paolo","Andreoli, Arnaldo","Avesani, Renato","Gamna, Federica","Grandi, Maurizio","Lombardi, Francesco","Lusuardi, Mirco","Molteni, Franco","Perboni, Alberto","Negrini, Stefano","32293817"],"abstract":["Covid-19 is a respiratory infectious disease that can cause respiratory, physical and psychological long-term dysfunctions in patients. First recommendations on respiratory management were published, but they were not based on the specific needs due to Covid-19. In this paper we share the early experiences from the clinical field in Northern Italy, where the epidemic started in February. This paper summarizes the second webinar on Covid-19 (230 live attendees, 11,600 viewers of the recorded version) organized by the Italian Society of Physical and Rehabilitation Medicine about rehabilitation and in particular respiratory management in the acute (Intensive Care Unit - ICU) and immediate post-acute phases. There is the need to prepare for the post-acute phase. ICU length of stay is relatively long, with immobilisation in prone position. Some specific problems are described, including severe muscle weakness and fatigue, joint stiffness, dysphagia, (neuro)psychological problems, impaired functioning concerning mobility, activities of daily life and work. A lot is yet unknown and patients can experience long-term consequences as we know from the literature on the post-intensive care syndrome, but Covid-19 has unique features to be investigated and understood. As one colleague stated during the Covinar: this is a marathon, not a sprint...."],"journal":"Eur J Phys Rehabil Med","authors":["Kiekens, Carlotte","Boldrini, Paolo","Andreoli, Arnaldo","Avesani, Renato","Gamna, Federica","Grandi, Maurizio","Lombardi, Francesco","Lusuardi, Mirco","Molteni, Franco","Perboni, Alberto","Negrini, Stefano"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32293817","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.23736/S1973-9087.20.06305-4","topics":["Prevention"],"weight":1,"_version_":1666138494471241728,"score":257.04337},{"pmid":32442317,"title":"The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).","text":["The case for Chronotherapy in COVID-19 induced Acute Respiratory Distress Syndrome (ARDS).","COVID-19, the disease resulting from infection by a novel coronavirus: SARS-Cov2 that has rapidly spread since November 2019 leading to a global pandemic. SARS-Cov2 has infected over 4 million people and caused over 290,000 deaths worldwide. Although most cases are mild, a subset of patients develop a severe and atypical presentation of Acute Respiratory Distress Syndrome (ARDS) that is characterised by a cytokine release storm (CRS). Paradoxically, treatment with anti-inflammatory agents and immune regulators has been associated with worsening of ARDS. We hypothesize that the intrinsic circadian clock of the lung and the immune system may regulate individual components of CRS and thus chronotherapy may be used to effectively manage ARDS in COVID-19 patients.","Br J Pharmacol","Tamimi, Faleh","Abusamak, Mohammad","Akkanti, Bindu","Chen, Zheng","Yoo, Seung-Hee","Karmouty-Quintana, Harry","32442317"],"abstract":["COVID-19, the disease resulting from infection by a novel coronavirus: SARS-Cov2 that has rapidly spread since November 2019 leading to a global pandemic. SARS-Cov2 has infected over 4 million people and caused over 290,000 deaths worldwide. Although most cases are mild, a subset of patients develop a severe and atypical presentation of Acute Respiratory Distress Syndrome (ARDS) that is characterised by a cytokine release storm (CRS). Paradoxically, treatment with anti-inflammatory agents and immune regulators has been associated with worsening of ARDS. We hypothesize that the intrinsic circadian clock of the lung and the immune system may regulate individual components of CRS and thus chronotherapy may be used to effectively manage ARDS in COVID-19 patients."],"journal":"Br J Pharmacol","authors":["Tamimi, Faleh","Abusamak, Mohammad","Akkanti, Bindu","Chen, Zheng","Yoo, Seung-Hee","Karmouty-Quintana, Harry"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32442317","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/bph.15140","topics":["Treatment","Mechanism"],"weight":1,"_version_":1667535119453257728,"score":232.4035},{"pmid":32280993,"pmcid":"PMC7188154","title":"Home and Community-Based Physical Therapist Management of Adults With Post-Intensive Care Syndrome.","text":["Home and Community-Based Physical Therapist Management of Adults With Post-Intensive Care Syndrome.","More than 4 million adults survive a stay in the intensive care unit each year, with many experiencing new or worsening physical disability, mental health problems, and/or cognitive impairments, known as the post-intensive care syndrome (PICS). Given the prevalence and magnitude of physical impairments after critical illness, many survivors, including those recovering from COVID-19, could benefit from physical therapist services after hospital discharge. However, due to the relatively recent recognition and characterization of PICS, there may be limited awareness and understanding of PICS among physical therapists practicing in home healthcare and community-based settings. This lack of awareness may lead to inappropriate and/or inadequate rehabilitation service provision. While this perspective article provides information relevant to all physical therapists, it is aimed toward those providing rehabilitation services outside of the acute and post-acute inpatient settings. This article reports the prevalence and clinical presentation of PICS and provides recommendations for physical examination and outcomes measures, plan of care, and intervention strategies. The importance of providing patient and family education, coordinating community resources including referring to other healthcare team members, and community-based rehabilitation service options is emphasized. Finally, this perspective article discusses current challenges for optimizing outcomes for people with PICS and suggests future directions for research and practice.","Phys Ther","Smith, James M","Lee, Alan C","Zeleznik, Hallie","Coffey Scott, Jacqueline P","Fatima, Arooj","Needham, Dale M","Ohtake, Patricia J","32280993"],"abstract":["More than 4 million adults survive a stay in the intensive care unit each year, with many experiencing new or worsening physical disability, mental health problems, and/or cognitive impairments, known as the post-intensive care syndrome (PICS). Given the prevalence and magnitude of physical impairments after critical illness, many survivors, including those recovering from COVID-19, could benefit from physical therapist services after hospital discharge. However, due to the relatively recent recognition and characterization of PICS, there may be limited awareness and understanding of PICS among physical therapists practicing in home healthcare and community-based settings. This lack of awareness may lead to inappropriate and/or inadequate rehabilitation service provision. While this perspective article provides information relevant to all physical therapists, it is aimed toward those providing rehabilitation services outside of the acute and post-acute inpatient settings. This article reports the prevalence and clinical presentation of PICS and provides recommendations for physical examination and outcomes measures, plan of care, and intervention strategies. The importance of providing patient and family education, coordinating community resources including referring to other healthcare team members, and community-based rehabilitation service options is emphasized. Finally, this perspective article discusses current challenges for optimizing outcomes for people with PICS and suggests future directions for research and practice."],"journal":"Phys Ther","authors":["Smith, James M","Lee, Alan C","Zeleznik, Hallie","Coffey Scott, Jacqueline P","Fatima, Arooj","Needham, Dale M","Ohtake, Patricia J"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32280993","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1093/ptj/pzaa059","keywords":["ambulatory care","critical illness","outpatients","post-intensive care syndrome"],"weight":0,"_version_":1666138491554103296,"score":230.08664},{"pmid":32376398,"title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.","text":["Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy.","A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili University Hospital in Brescia (Italy) between March 9th and March 20th with confirmed COVID-19 pneumonia and ARDS requiring ventilatory support was analyzed to determine whether intravenous administration of tocilizumab (TCZ), a monoclonal antibody that targets the interleukin 6 receptor, was associated with improved outcome. Tocilizumab was administered at a dosage of 8mg/kg by two consecutive intravenous infusions 12h apart. A third infusion was optional based on clinical response. The outcome measure was an improvement in ARDS assessed by means of the Brescia COVID Respiratory Severity Score (BCRSS 0 to 8, with higher scores indicating higher severity) at 24-72h and 10days after tocilizumab administration. Out of 100 treated patients (88M, 12F; median age: 62years), 43 received TCZ in the intensive care unit (ICU), while 57 in the general ward as no ICU beds were available. Of these 57 patients, 37 (65%) improved and suspended noninvasive ventilation (NIV) (median BCRSS: 1 [IQR 0-2]), 7 (12%) patients remained stable in NIV, and 13 (23%) patients worsened (10 died, 3 were admitted to ICU). Of the 43 patients treated in ICU, 32 (74%) improved (17 of them were taken off the ventilator and were discharged to the ward), 1 (2%) remained stable (BCRSS: 5) and 10 (24%) died (all of them had BCRSS>/=7 before TCZ). Overall at 10days, the respiratory condition was improved or stabilized in 77 (77%) patients, of whom 61 showed a significant clearing of diffuse bilateral opacities on chest x-ray and 15 were discharged from the hospital. Respiratory condition worsened in 23 (23%) patients, of whom 20 (20%) died. All the patients presented with lymphopenia and high levels of C-reactive protein (CRP), fibrinogen, ferritin and interleukin 6 (IL-6) indicating a HIS. During the 10-day follow-up, three cases of severe adverse events were recorded: two patients developed septic shock and died, one had gastrointestinal perforation requiring urgent surgery and was alive at day 10. In conclusion, our series showed that COVID-19 pneumonia with ARDS was characterized by HIS. The response to TCZ was rapid, sustained, and associated with significant clinical improvement.","Autoimmun Rev","Toniati, Paola","Piva, Simone","Cattalini, Marco","Garrafa, Emirena","Regola, Francesca","Castelli, Francesco","Franceschini, Franco","Foca, Emanuele","Andreoli, Laura","Latronico, Nicola","32376398"],"abstract":["A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili University Hospital in Brescia (Italy) between March 9th and March 20th with confirmed COVID-19 pneumonia and ARDS requiring ventilatory support was analyzed to determine whether intravenous administration of tocilizumab (TCZ), a monoclonal antibody that targets the interleukin 6 receptor, was associated with improved outcome. Tocilizumab was administered at a dosage of 8mg/kg by two consecutive intravenous infusions 12h apart. A third infusion was optional based on clinical response. The outcome measure was an improvement in ARDS assessed by means of the Brescia COVID Respiratory Severity Score (BCRSS 0 to 8, with higher scores indicating higher severity) at 24-72h and 10days after tocilizumab administration. Out of 100 treated patients (88M, 12F; median age: 62years), 43 received TCZ in the intensive care unit (ICU), while 57 in the general ward as no ICU beds were available. Of these 57 patients, 37 (65%) improved and suspended noninvasive ventilation (NIV) (median BCRSS: 1 [IQR 0-2]), 7 (12%) patients remained stable in NIV, and 13 (23%) patients worsened (10 died, 3 were admitted to ICU). Of the 43 patients treated in ICU, 32 (74%) improved (17 of them were taken off the ventilator and were discharged to the ward), 1 (2%) remained stable (BCRSS: 5) and 10 (24%) died (all of them had BCRSS>/=7 before TCZ). Overall at 10days, the respiratory condition was improved or stabilized in 77 (77%) patients, of whom 61 showed a significant clearing of diffuse bilateral opacities on chest x-ray and 15 were discharged from the hospital. Respiratory condition worsened in 23 (23%) patients, of whom 20 (20%) died. All the patients presented with lymphopenia and high levels of C-reactive protein (CRP), fibrinogen, ferritin and interleukin 6 (IL-6) indicating a HIS. During the 10-day follow-up, three cases of severe adverse events were recorded: two patients developed septic shock and died, one had gastrointestinal perforation requiring urgent surgery and was alive at day 10. In conclusion, our series showed that COVID-19 pneumonia with ARDS was characterized by HIS. The response to TCZ was rapid, sustained, and associated with significant clinical improvement."],"journal":"Autoimmun Rev","authors":["Toniati, Paola","Piva, Simone","Cattalini, Marco","Garrafa, Emirena","Regola, Francesca","Castelli, Francesco","Franceschini, Franco","Foca, Emanuele","Andreoli, Laura","Latronico, Nicola"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376398","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.autrev.2020.102568","locations":["Brescia","Italy","Brescia","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"e_drugs":["tocilizumab"],"topics":["Treatment"],"weight":1,"_version_":1666262687630229504,"score":214.75224},{"pmid":32331955,"pmcid":"PMC7166308","title":"Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.","text":["Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.","BACKGROUND: In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia. METHODS: We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19. RESULTS: There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34], p < 0.001; I(2): 65%). Cardiac injury was associated with higher need for ICU care (RR 7.94 [1.51, 41.78], p = 0.01; I(2): 79%), and severe COVID-19 (RR 13.81 [5.52, 34.52], p < 0.001; I(2): 0%). The cardiac injury was not significant for increased risk of ARDS (RR 2.57 [0.96, 6.85], p = 0.06; I(2): 84%). The level of hs-cTnI was higher in patients with primary + secondary outcome (mean difference 10.38 pg/mL [4.44, 16.32], p = 0.002; I(2): 0%). CONCLUSION: Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19.","Am J Emerg Med","Santoso, Anwar","Pranata, Raymond","Wibowo, Arief","Al-Farabi, Makhyan Jibril","Huang, Ian","Antariksa, Budhi","32331955"],"abstract":["BACKGROUND: In this systematic review and meta-analysis, we aimed to explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia. METHODS: We performed a comprehensive literature search from several databases. Definition of cardiac injury follows that of the included studies, which includes highly sensitive cardiac troponin I (hs-cTnl) >99th percentile.The primary outcome was mortality, and the secondary outcomes were ARDS, the need for ICU care, and severe COVID-19. ARDS and severe COVID-19 were defined per the World Health Organization (WHO) interim guidance of severe acute respiratory infection (SARI) of COVID-19. RESULTS: There were a total of 2389 patients from 13 studies. This meta-analysis showed that cardiac injury was associated with higher mortality (RR 7.95 [5.12, 12.34], p < 0.001; I(2): 65%). Cardiac injury was associated with higher need for ICU care (RR 7.94 [1.51, 41.78], p = 0.01; I(2): 79%), and severe COVID-19 (RR 13.81 [5.52, 34.52], p < 0.001; I(2): 0%). The cardiac injury was not significant for increased risk of ARDS (RR 2.57 [0.96, 6.85], p = 0.06; I(2): 84%). The level of hs-cTnI was higher in patients with primary + secondary outcome (mean difference 10.38 pg/mL [4.44, 16.32], p = 0.002; I(2): 0%). CONCLUSION: Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19."],"journal":"Am J Emerg Med","authors":["Santoso, Anwar","Pranata, Raymond","Wibowo, Arief","Al-Farabi, Makhyan Jibril","Huang, Ian","Antariksa, Budhi"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331955","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ajem.2020.04.052","keywords":["covid-19","cardiac injury","coronavirus","mortality","troponin"],"topics":["Treatment"],"weight":1,"_version_":1666138494006722560,"score":214.65189}]}